AI news impact · China A-shares

Shijiazhuang Yiling Pharmaceutical Co., Ltd. Class A (002603) news impact

On 2026-10-30 Wave Radar's AI rated the news on Shijiazhuang Yiling Pharmaceutical Co., Ltd. Class A as neutral (impact score +35%).

Yiling Pharma posted 9M revenue of 5.968 billion yuan and net profit of 1.096 billion yuan (+9.55% YoY), with operating cash flow up 25.86%.

Direction
Neutral
Impact score
+35%
Confidence
85%
Headlines read
4
Date
2026-10-30
Open 002603 news in Wave Radar

AI assessment

Steady 9.55% earnings growth paired with a 25.86% surge in operating cash flow underscores healthy financial operations.

Sector impact

Steady performance offers positive support for traditional Chinese medicine peers with moderate spillover.

Headlines the AI read

Rating history

One rating per trading day the stock was covered.

More on Shijiazhuang Yiling Pharmaceutical Co., Ltd. Class A

002603 valuation

How the rating works

After each close Wave Radar collects the day's headlines and filings for a stock and asks an AI model what they mean for it. The rating is one of five levels from major negative to major positive; the impact score runs from −100% to +100%, and a rating built on a single uncorroborated source is capped. It describes the news, not the price outlook.

Figures are generated automatically from Wave Radar's published market data and refresh after each market close.